Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning
Intub_prone
Intubation Prediction in Sars-CoV-2 Patients Treated With Awake Prone Positioning
1 other identifier
observational
42
1 country
1
Brief Summary
Retrospective study in Sars-Cov 2 patients hospitalised in ICU. We aim to explore the effects of Awake prone positioning on oxygenation and intubation rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2021
CompletedStudy Start
First participant enrolled
September 16, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedJune 3, 2022
September 1, 2021
8 months
September 16, 2021
June 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Intubation rate
Once between ICU admission and extubation
Secondary Outcomes (4)
Alveolo-arterial gradient change
Within 6 hours before and 6 hours after each pronation
Blood gas analysis
Within 6 hours before and 6 hours after each pronation
Respiratory pattern
Within 6 hours before and 6 hours after each pronation
Mortality
Up to 28 days from ICU admission
Interventions
Awake prone position as long as possible according to the patients' tolerance
Eligibility Criteria
Sars-CoV-2 pneumonia patients with severe hypoxemia
You may qualify if:
- Sars-CoV-2 pneumonia
- ICU stay
- Severe hypoxemia but non intubated
You may not qualify if:
- Intubated before admission
- Denied consent for data analysis
- Do not intubate order at ICU admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lausanne University Hospitals
Lausanne, Canton of Vaud, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 16, 2021
First Posted
September 29, 2021
Study Start
September 16, 2021
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
June 3, 2022
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share